国产精华推荐2021,欧美性BBBBBXXXXXXX,国产乱妇无乱码大黄aa片,国产97在线 | 中文

當(dāng)前位置:首頁  >  技術(shù)文章  >  EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)

更新時(shí)間:2024-12-28  |  點(diǎn)擊率:114

20231月,汕頭大學(xué)醫(yī)學(xué)院第二附屬醫(yī)院泌尿外科;廣州醫(yī)科大學(xué)第五附屬醫(yī)院泌尿外科;中山大學(xué)第一附屬醫(yī)院泌尿外科 (Department of Urology, The Second Affiliated Hospital of Shantou University, Medical College,Shantou 515041, ChinaDepartment of Urology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China;Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China) Hao Lin老師研究團(tuán)隊(duì)在《Cancers》上發(fā)表論文:

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer"

 

EPHA3可能是一種新的預(yù)后生物標(biāo)志物并與膀胱癌免疫浸潤相關(guān)"

 

Abstract

Purpose: To assess the mechanism of EPH receptor A3 (EPHA3) and its potential value for immunotherapy in BLCA.

Materials and methods: The Cancer Genome Atlas (TCGA) bladder cancer (BLCA) database and the Gene Expression Omnibus (GEO) database were used for assessing whether EHPA3 could be used to predict BLCA prognosis. This work carried out in vitro and in vivo assays for exploring how EPHA3 affected the biological behaviors. The downstream pathway was explored using a Western blotting technique. The CIBERSORT, ESTIMATE, TIMER, and TIDE tools were used to predict the immunotherapy value of EPHA3 in BLCA.

Results: EPHA3 was poorly expressed in BLCA (p < 0.05), its high expression is related to a good survival prognosis (p = 0.027 and p = 0.0275), and it has a good predictive ability for the histologic grade and status of BLCA (area under curve = 0.787 and 0.904). Overexpressed EPHA3 could inhibit BLCA cell biological behaviors, and it be associated with the downregulation of the Ras/pERK1/2 pathway. EPHA3 was correlated with several immune-infiltrating cells and the corresponding marker genes.

Conclusions: EPHA3 could be regarded as an acceptable anti-cancer biomarker in BLCA. EPHA3 plays an inhibiting role in BLCA, and it could be the candidate immunotherapeutic target for BLCA.


摘要:

目的:探討EPH受體A3 (EPHA3)的作用機(jī)制及其在BLCA免疫治療中的潛在價(jià)值。材料與方法:采用Cancer Genome Atlas (TCGA)膀胱癌(BLCA)數(shù)據(jù)庫和Gene Expression Omnibus (GEO)數(shù)據(jù)庫評估EHPA3是否可用于預(yù)測BLCA預(yù)后。本工作通過體外和體內(nèi)實(shí)驗(yàn)探討EPHA3對生物行為的影響。使用Western blotting技術(shù)探索下游途徑。采用CIBERSORT、ESTIMATE、TIMERTIDE工具預(yù)測EPHA3BLCA中的免疫治療價(jià)值。結(jié)果:EPHA3BLCA中表達(dá)較低(p < 0.05),其高表達(dá)與較好的生存預(yù)后相關(guān)(p = 0.027p = 0.0275),對BLCA的組織學(xué)分級和狀態(tài)有較好的預(yù)測能力(曲線下面積分別為0.7870.904)EPHA3過表達(dá)可抑制BLCA細(xì)胞的生物學(xué)行為,并與Ras/pERK1/2通路下調(diào)有關(guān)。EPHA3與多種免疫浸潤細(xì)胞及相應(yīng)的標(biāo)記基因相關(guān)。結(jié)論:EPHA3可作為BLCA的一種可接受的抗癌生物標(biāo)志物。EPHA3BLCA中具有抑制作用,可能成為BLCA的候選免疫治療靶點(diǎn)。

 

該論文中,人類膀胱癌細(xì)胞(5637、UMUC-3T24)以及正常的人類尿上皮細(xì)胞(SVHUC)的體外培養(yǎng)是使用Ausbian特級胎牛血清完成的。


中文字幕一区二区三区乱码| 少妇一夜十三次精尽人亡| 欧美变态口味重另类在线视频| 色噜噜综合熟女人妻一区| 精品久久8x国产免费观看| 国产97在线 | 日韩| 亚洲国产成人无码AV在线播放| 久久精品水蜜桃av综合天堂 | 欧美老人巨大XXXX做受| 欧美熟妇另类久久久久久多毛 | 粉嫩AV久久一区二区三区| 亚洲熟妇成人精品一区| 日产精品一线二线三线区| 姐姐3免费观看完整版| 精品无码国产一区二区三区51安 | 亚洲人交乣女bbw| 久久精品国产亚洲AV麻豆| 无码av人妻精品一区二区三区抖音| 向风而行免费观看完整版| 人妻夜夜爽天天爽三区麻豆av网站| 亚洲国产精品va在线看黑人| 天下第一日本www视频| av无码国产精品午夜a片| 国产乱子伦在线观看| 伦理片在线观看| 国产suv精品一区二区69| 中国人体艺术视频| 玩弄人妻少妇500系列网址| 久久久久精品无码专区| AV大片在线无码永久免费| 精品国产亚洲一区二区三区在线观看 | 亚洲人成色777777在线播放| 苍井空亚洲精品aa片在线播放| 亚洲不卡无码AV中文字幕| 国产免费av片在线无码免费看| 各种少妇正面着bbw撒尿视频| 色婷婷综合久久久久中文| 扒开双腿疯狂进出爽爽爽视频| 久久人人槡人妻人人玩夜色av| 国产亚洲精品A在线无码麻豆| 日韩精品无码一本二本三本色|